The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation.
In the present study, we have analyzed the pattern of cytokines expressed by two independent dendritic cell (DC) subpopulations generated in vitro from human cord blood CD34+ progenitors cultured with granulocyte-macrophage CSF and TNF-alpha. Molecularly, we confirmed the phenotypic differences discriminating the two subsets: E-cadherin mRNA was only detected in CD1a+-derived DC, whereas CD68 and factor XIIIa mRNAs were observed exclusively in CD14+-derived DC. Semiquantitative reverse-transcriptase PCR analysis revealed that both DC subpopulations spontaneously expressed IL-1alpha, IL-1beta, IL-6, IL-7, IL-12 (p35 and p40), IL-15, IL-18, TNF-alpha, TGF-beta, macrophage CSF, and granulocyte-macrophage CSF, but not IL-2, IL-3, IL-4, IL-5, IL-9, and IFN-gamma transcripts. Both subpopulations were shown to secrete IL-12 after CD40 triggering. Interestingly, only the CD14+-derived DC secreted IL-10 after CD40 activation, strengthening the notion that the two DC subpopulations indeed represent two independent pathways of DC development. Furthermore, both DC subpopulations expressed IL-13 mRNA and protein following activation with PMA-ionomycin, but not with CD40 ligand, in contrast to IL-12 and IL-10, revealing the existence of different pathways for DC activation. Finally, we confirmed the expression of IL-7, IL-10, and IL-13 mRNA by CD4+ CD11c+ CD3- DC isolated ex vivo from tonsillar germinal centers. Thus, CD14+-derived DC expressing IL-10 and factor XIIIa seemed more closely related to germinal center dendritic cellsGCDC than to Langerhans cells.
de Saint-Vis
B
B
Schering-Plough, Laboratory for Immunological Research, Dardilly, France.
Fugier-Vivier
I
I
Massacrier
C
C
Gaillard
C
C
Vanbervliet
B
B
Aït-Yahia
S
S
Banchereau
J
J
Liu
Y J
YJ
Lebecque
S
S
Caux
C
C
D018949:Antigens, CD1 / Q000032:analysis; D018952:Antigens, CD34 / Q000032:analysis; D002478:Cells, Cultured; D002648:Child; D016207:Cytokines / Q000096:biosynthesis* / Q000235:genetics; D003713:Dendritic Cells / Q000145:classification / Q000276:immunology* / Q000378:metabolism*; D005312:Fetal Blood / Q000166:cytology / Q000276:immunology; D006412:Hematopoietic Stem Cells / Q000276:immunology; D006801:Humans; D016753:Interleukin-10 / Q000096:biosynthesis; D018664:Interleukin-12 / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism; D018793:Interleukin-13 / Q000096:biosynthesis; D020382:Interleukin-18; D015851:Interleukin-7 / Q000096:biosynthesis / Q000235:genetics; D015759:Ionomycin / Q000494:pharmacology; D007801:Langerhans Cells / Q000276:immunology / Q000378:metabolism; D018950:Lipopolysaccharide Receptors / Q000032:analysis; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000096:biosynthesis; D015398:Signal Transduction / Q000187:drug effects / Q000276:immunology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D018949:Antigens, CD1; D018952:Antigens, CD34; D016207:Cytokines; D018793:Interleukin-13; D020382:Interleukin-18; D015851:Interleukin-7; D018950:Lipopolysaccharide Receptors; D012333:RNA, Messenger; D016753:Interleukin-10; D018664:Interleukin-12; D015759:Ionomycin; D013755:Tetradecanoylphorbol Acetate